Aptevo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aptevo Therapeutics

12/08/2021 16:50

* Aptevo Therapeutics Inc  APVO.OQ  reported a quarterly
adjusted loss of $1.75​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of $1.84 per share.
* Revenue rose 557.5% to $3.11 million from a year ago; 
analysts expected $900.00 thousand. 
* Aptevo Therapeutics Inc's reported EPS for the quarter was a
loss of $1.75​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Aptevo Therapeutics Inc shares had fallen by 21.4% this
quarter and lost 51.9% so far this year.
* The company reported a quarterly loss of $7.93 million.
* Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $64.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 03:50 p.m.  ​All
figures in US dollars unless otherwise stated